Advertisement
Advertisement
IXHL
Incannex Healthcare Limited - ADR
3.23
USDSponsored
+0.45
+16.12%
Mar 25, 16:00 UTC -4
Closed
After-Market
3.15
-0.07
-2.26%
IXHL Earnings Reports
Positive Surprise Ratio
IXHL beat 3 of 6 last estimates.
50%
Next Report
Date of Next Report
May 13, 2026
Estimate for Q3 26 (Revenue/ EPS)
--
/-$0.94
Implied change from Q2 26 (Revenue/ EPS)
--
/+56.67%
Implied change from Q3 25 (Revenue/ EPS)
--
/-99.61%
Incannex Healthcare Limited - ADR earnings per share and revenue
On Feb 13, 2026, IXHL reported earnings of -0.60 USD per share (EPS) for Q2 26, beating the estimate of -0.94 USD, resulting in a 36.50% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +0.04% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 3 analysts forecast an EPS of -0.94 USD, with revenue projected to reach -- USD, implying an increase of 56.67% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Talphera, Inc. Common Stock
Report Date
Mar 23, 2026 For Q4 25
Estimate
-$0.08
Actual
-$0.06
Surprise
+26.47%
Theravance Biopharma, Inc.
Report Date
Mar 19, 2026 For Q4 25
Estimate
$1.24
Actual
$0.21
Surprise
-83.12%
Relmada Therapeutics, Inc. Common Stock
Report Date
Mar 19, 2026 For Q4 25
Estimate
-$0.14
Actual
-$0.28
Surprise
-103.08%
Context Therapeutics Inc. Common Stock
Report Date
Mar 23, 2026 For Q4 25
Estimate
-$0.10
Actual
-$0.14
Surprise
-29.39%
Avalo Therapeutics, Inc. Common Stock
Report Date
Mar 23, 2026 For Q4 25
Estimate
-$1.49
Actual
-$1.12
Surprise
+24.33%
Journey Medical Corporation Common Stock
Report Date
Mar 25, 2026 For Q4 25
Estimate
-$0.05
Actual
-$0.04
Surprise
+31.86%
Surrozen, Inc. Common
Report Date
Mar 30, 2026 For Q4 25
Estimate
-$1.21
Actual
-Surprise
-
Achieve Life Sciences, Inc.
Report Date
Mar 24, 2026 For Q4 25
Estimate
-$0.27
Actual
-$0.28
Surprise
-1.12%
Pyxis Oncology, Inc. Common Stock
Report Date
Mar 23, 2026 For Q4 25
Estimate
-$0.34
Actual
-$0.28
Surprise
+15.55%
Fractyl Health, Inc. Common Stock
Report Date
Mar 24, 2026 For Q4 25
Estimate
-$0.18
Actual
$0.15
Surprise
+181.70%
FAQ
What were Incannex Healthcare Limited - ADR's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Incannex Healthcare Limited - ADR reported EPS of -$0.60, beating estimates by 36.5%, and revenue of --, 0% as expectations.
How did the market react to Incannex Healthcare Limited - ADR's Q2 2026 earnings?
The stock price moved up 0.04%, changed from $0.27 before the earnings release to $0.27 the day after.
When is Incannex Healthcare Limited - ADR expected to report next?
The next earning report is scheduled for May 13, 2026.
What are the forecasts for Incannex Healthcare Limited - ADR's next earnings report?
Based on 3
analysts, Incannex Healthcare Limited - ADR is expected to report EPS of -$0.94 and revenue of -- for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement